IL6 and neoplasm: Interestingly, HNSCCs constitute a tumour environment that promotes Th17 cell activity due to the release of IL-23 and IL-6 by the neoplastic cells themselves and by TIL and IL-1β by immune cells infiltrating the cancer niche [297].